183 related articles for article (PubMed ID: 11350542)
1. Iron and hepatocellular carcinoma.
Deugnier Y; Turlin B
J Gastroenterol Hepatol; 2001 May; 16(5):491-4. PubMed ID: 11350542
[TBL] [Abstract][Full Text] [Related]
2. Iron in the pathogenesis of hepatocellular carcinoma.
Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
[TBL] [Abstract][Full Text] [Related]
3. Iron overload and hematologic malignancies.
Franchini M; Veneri D
Hematol J; 2004; 5(5):381-3. PubMed ID: 15448663
[TBL] [Abstract][Full Text] [Related]
4. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in non-cirrhotic liver without evidence of iron overload in a patient with primary hemochromatosis. Review.
Singh P; Kaur H; Lerner RG; Patel R; Rafiyath SM; Singh Lamba G
J Gastrointest Cancer; 2012 Mar; 43(1):36-9. PubMed ID: 20872293
[TBL] [Abstract][Full Text] [Related]
7. [Iron overload and cancer].
Blanc JF; Bioulac-Sage P; Balabaud C
Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
[TBL] [Abstract][Full Text] [Related]
8. Iron, hemochromatosis, and hepatocellular carcinoma.
Kowdley KV
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S79-86. PubMed ID: 15508107
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and African iron overload.
Gangaidzo IT; Gordeuk VR
Gut; 1995 Nov; 37(5):727-30. PubMed ID: 8549953
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of hepatocellular carcinoma arising in genetic hemochromatosis.
Lwakatare F; Hayashida Y; Yamashita Y
Magn Reson Med Sci; 2003 Apr; 2(1):57-9. PubMed ID: 16210821
[TBL] [Abstract][Full Text] [Related]
11. Non-viral causes of hepatocellular carcinoma.
Blonski W; Kotlyar DS; Forde KA
World J Gastroenterol; 2010 Aug; 16(29):3603-15. PubMed ID: 20677332
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis.
Maakaron JE; Cappellini MD; Graziadei G; Ayache JB; Taher AT
Ann Hepatol; 2013; 12(1):142-6. PubMed ID: 23293206
[TBL] [Abstract][Full Text] [Related]
13. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.
Harrison SA; Bacon BR
Med Clin North Am; 2005 Mar; 89(2):391-409. PubMed ID: 15656932
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma.
Marrogi AJ; Khan MA; van Gijssel HE; Welsh JA; Rahim H; Demetris AJ; Kowdley KV; Hussain SP; Nair J; Bartsch H; Okby N; Poirier MC; Ishak KG; Harris CC
J Natl Cancer Inst; 2001 Nov; 93(21):1652-5. PubMed ID: 11698570
[No Abstract] [Full Text] [Related]
15. Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort: A prospective longitudinal observational study.
Nowak A; Giger RS; Krayenbuehl PA
Medicine (Baltimore); 2018 Oct; 97(42):e12886. PubMed ID: 30335010
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic.
Moukhadder HM; Roumi JE; Bou-Fakhredin R; Taher AT
Hemoglobin; 2018 Jan; 42(1):58-60. PubMed ID: 29493312
[TBL] [Abstract][Full Text] [Related]
17. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
18. An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
Mogl MT; Pascher A; Presser SJ; Schwabe M; Neuhaus P; Nuessler NC
World J Gastroenterol; 2007 Apr; 13(13):1998-2001. PubMed ID: 17461505
[TBL] [Abstract][Full Text] [Related]
19. Hepatic iron overload and hepatocellular carcinoma.
Kew MC
Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
[TBL] [Abstract][Full Text] [Related]
20. A liver mass in an iron-overloaded thalassaemia intermedia patient.
Maakaron JE; Musallam KM; Ayache JB; Jabbour M; Tawil AN; Taher AT
Br J Haematol; 2013 Apr; 161(1):1. PubMed ID: 23294457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
